Showing results (2261-2270 of 3,072) with videos related to
Sort By:
Pageof 308
Chemotherapy|January 1, 1977
Kinetics of reduction in viability of cultured leukemia L1210 cells exposed to purine analogsL J Wilkoff, E A Dulmadge, H H LloydChemotherapy|January 1, 1987
Comparative in vitro activity of carumonam (Ro 17-2301/AMA-1080), a new monobactam, and ceftriaxone against aerobic or facultative gram-negative isolatesC A Barclay, M A Iribarren, M Goldberg, et al.Chemotherapy|November 11, 2022
Ibrutinib and Bruton's Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Focus on Atrial Fibrillation and Ventricular Tachyarrhythmias/Sudden Cardiac DeathGiuseppe Boriani, Pierantonio Menna, Riccardo Morgagni, et al.Chemotherapy|March 9, 2023
Circulating Endothelial Cell Kinetic in Patients with Multiple Myeloma Who Receive Autologous Hematopoietic Stem Cell TransplantationOmbretta Annibali, Valeria Tomarchio, Chiara Gregorj, et al.Chemotherapy|November 16, 2022
Curcumin Suppresses the Progression of Colorectal Cancer by Improving Immunogenic Cell Death Caused by IrinotecanCunliang Zhu, Zhaobi Fang, Lei Peng, et al.Chemotherapy|January 22, 2025
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-Small Cell Lung CancerDaiki Murata, Koichi Azuma, Yuuya Nishii, et al.Chemotherapy|November 18, 2024
Phase I Clinical Study of a Multi-Kinase Inhibitor TG02 Capsule for the Treatment of Recurrent High-Grade Gliomas with Failed Temozolomide Treatment in Chinese PatientsCheng-Cheng Guo, Qun-Ying Yang, Shao-Yan Xi, et al.Chemotherapy|June 16, 2024
Successful Isavuconazole Treatment for Pulmonary Mucormycosis in a Patient Intolerant to Liposomal Amphotericin B with Pharmacokinetic Insights: A Case ReportTakeo Yasu, Makoto Hoshino, Naoya Sakamoto, et al.Chemotherapy|May 19, 2024
The Study of SRSF1 Regulates Abnormal Alternative Splicing of BCL2L11 and the Role in Refractory Acute Myeloid LeukemiaQirong Wang, Yu Duan, Zhifang Zan, et al.Chemotherapy|December 19, 2023
3-4 Cycles versus 6 Cycles Neoadjuvant Chemotherapy in Advanced-Stage Epithelial Ovarian Cancer: Survival Is Not Determined by the Number of Neoadjuvant Chemotherapy CyclesTugan Bese, Elifnur Bicer, Basak Ozge Kayan, et al.Pageof 308